Skip to main content
. 2015 Jun 24;6(19):17031–17038. doi: 10.18632/oncotarget.4400

Table 2. Association between LogP and hepatic adverse drug reactions.

LogP Group (Drug Number) LogP < 1(n = 214) 1 ≤ LogP < 3(n = 378) LogP ≥ 3(n = 360) P-value
hADR Type
Fatal hADRs 35 (16%) 46 (12%) 68 (19%) 2.35E-01
Liver Failure 55 (26%) 64 (17%) 88 (24%) 8.97E-01
Liver Transplantation 9 (4%) 8 (2%) 20 (6%) 2.41E-01
Jaundice 69 (32%) 98 (26%) 141 (39%) 2.43E-02*
Biomarker Increase 54 (25%) 94 (25%) 101 (28%) 3.94E-01
Hepatomegaly 19 (9%) 23 (6%) 19 (5%) 1.04E-01
Hepatitis 68 (32%) 107 (28%) 115 (32%) 8.15E-01
Severe hADRs 58 (27%) 72 (19%) 94 (26%) 8.69E-01
All hADRs 105 (49%) 177 (47%) 192 (53%) 2.23E-01

P value was determined using the Cochran-Armitage test.

*

P < 0.05

**

P < 0.01

***

P < 0.001